Regeneron forms consortium to fund exome sequencing

12-01-2018

Regeneron forms consortium to fund exome sequencing

cosmin4000 / iStockphoto.com

Regeneron Pharmaceuticals has formed a consortium with five other companies to fund the generation of exome sequence data from 500,000 volunteers in the UK.


Regeneron, AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen, Pfizer, genetics, biobank, sequencing, human genetics

LSIPR